Skip to content

SPARC: Shoulder PAtch for Rotator Cuff Tears

SPARC: Shoulder PAtch for Rotator Cuff Tears

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02049684
Enrollment
60
Registered
2014-01-30
Start date
2013-01-01
Completion date
2018-03-31
Last updated
2019-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Massive Rotator Cuff Tears

Brief summary

Rotator cuff tears (injury to the muscle or tendons which stabilise the shoulder) are one of the most common conditions affecting the shoulder. Small and medium sized rotator cuff tears can be managed with arthroscopic or keyhole surgery. Very large or massive tears are difficult to operate on and often have poor rates of healing. As a result surgeons have investigated the use of products to improve the outcome of surgery on massive tears. The product that the investigators are currently using to try to improve the outcome of surgery for massive rotator cuff tears is called a patch. The patch provides a scaffold to support the muscles of the rotator cuff. Studies of rotator cuff surgery using similar patches have found that recovery is improved and there is a lower rate of postsurgical problems. The aim of this study is to look at whether using the patch improves pain and the clinical function of the shoulder after surgery. In addition, the investigators would like to understand how the patch works. To do this the investigators will scan (take images of) the shoulder using magnetic resonance imaging to look at the muscle damage in the shoulder before and after surgery.

Interventions

PROCEDUREPatch

Sponsors

The Leeds Teaching Hospitals NHS Trust
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 95 Years
Healthy volunteers
No

Inclusion criteria

* Ultrasound confirming massive rotator full thickness tear, unacceptable pain and disability following conservative treatment, or previous surgery that has failed, deltoid muscle that is functional, and compliance with post operative rehabilitation.

Exclusion criteria

* History of infection * Neurological condition that affects the shoulder girdle * Presence of rotator cuff arthropathy with stiffness * Subjects with inability to give informed consent * Pregnancy or lactation * Malignancy * Age less than 18 years * Subjects currently participating in other research studies * Subjects with the following contraindications to MRI scanning will not have an MR scan but may be asked to have alternative imaging, for example ultrasound: * Pacemakers * Surgical clips within the head * Certain inner ear implants * Neuroelectrical stimulators * Metal fragments within the eye or head * Pregnant or breastfeeding women

Design outcomes

Primary

MeasureTime frameDescription
Change in supraspinatus, infraspinatous and subscapularis water:fat ratioBaseline and 6 months post surgeryChange in supraspinatus, infraspinatous and subscapularis water:fat ratio, assessed by MRI, 6 months postsurgery/ physiotherapy compared to baseline (presurgery/physiotherapy)

Secondary

MeasureTime frameDescription
Change in function, pain and patient satisfaction (Oxford Shoulder Score, EQ5D, Constant Score)Baseline and 6 months post surgeryChange in function, pain and patient satisfaction (Oxford Shoulder Score, EQ5D, Constant Score)
Change in muscle volume (MRI assessment) for the supraspinatus, infraspinatous and subscapularisBaseline and 6 months post-surgeryChange in muscle volume (MRI assessment) for the supraspinatus, infraspinatous and subscapularis
Change in Goutallier score of muscle atrophy and fatty infiltration (MRI assessment) for the supraspinatus, infraspinatous and subscapularisBaseline and 6 months post-surgeryChange in Goutallier score of muscle atrophy and fatty infiltration (MRI assessment) for the supraspinatus, infraspinatous and subscapularis

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026